DBV Technologies S.A.: DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 - 3 Years After Receiving Pre-BLA Responses from FDA
Montrouge, France, April 19, 2023 DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 - 3 Years After Receiving Pre-BLA Responses from FDA The FDA confirmed that the